natgillin/translations-raw huggingface dataset:
Farmakoterapeutisk gruppe:Ektoparasitært middel til topikal anvendelse.ATCvet-kode: QP53AX26.
Pharmacotherapeutic group: Ectoparasiticides for topical use; ATCvet code: QP53AX26
Farmakoterapeutisk klassifikation - Antivirale midler til systemisk brug, nukleosid og nukleotid revers transkriptase-hæmmere, ATC-kode: J05AF05..
Pharmacotherapeutic group - Antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors,ATC Code: J05AF05.
Farmakoterapeutisk klassifikation : Antineoplastiske stoffer, plantealkaloider og andre naturprodukter, taxaner, ATC kode: L01CD 02
Pharmacotherapeutic group: antineoplastic agents, plant alkaloids and other natural products,taxanes, ATC Code: L01CD02
Farmakoterapeutisk klassifikation : Taxaner, ATC kode: L01CD 02 Virkningsmekanisme
Pharmacotherapeutic group: Taxanes, ATC Code: L01CD 02 Mechanism of action
Farmakoterapeutisk klassifikation : Taxaner, ATC kode: L01CD02 Virkningsmekanisme
Pharmacotherapeutic group: Taxanes, ATC Code: L01CD02 Mechanism of action
Farmakoterapeutisk klassifikation – Antivirale midler til systemisk brug, nukleosid og nukleotid revers transkriptase-hæmmere, ATC-kode: J05A F05.
Pharmacotherapeutic group - Antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors, ATC Code: J05AF05.
Farmakoterapeutisk klassifikation – Antivirale midler til systemisk brug, nukleosid og nukleotid revers transkriptase-hæmmere, ATC-kode: J05AF05.
Pharmacotherapeutic group - Antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors, ATC Code: J05AF05.
Farmakoterapeutisk klassifikation: <endnu ikke tildelt>, ATC-kode: <endnu ikke tildelt>
Pharmacotherapeutic group: <not yet assigned>, ATC code: <not yet assigned>
Farmakoterapeutisk klassifikation: Aminosyrer og derivater; ATC Kode: A16A A05 Virkningsmekanisme
Pharmacotherapeutic group: Amino acids and derivatives; ATC code: A16AA05 Mechanism of action
Farmakoterapeutisk klassifikation: Analgetika; Opioider , ATC-kode: N02AB03 Virkningsmekanisme
Pharmacotherapeutic group: Analgesics, opioids, ATC code: N02AB03 Mechanism of action
Farmakoterapeutisk klassifikation: Analgetika; Opioider, ATC-kode: N02AB03 Virkningsmekanisme
Pharmacotherapeutic group: Analgesics, opioids, ATC code: N02AB03 Mechanism of action
Farmakoterapeutisk klassifikation: analgetika; opioider; ATC-kode: N02AB03.
Pharmacotherapeutic group: analgesics; opioids;; ATC code N02AB03.
Farmakoterapeutisk klassifikation: Andre antidemenspræparater, ATC-kode: N06DX01.
Pharmacotherapeutic group: Other Anti-dementia drugs, ATC code: N06DX01.
Farmakoterapeutisk klassifikation: Andre antihypertensiva, ATC-kode: C02KX01 Virkningsmekanisme
Pharmacotherapeutic group: other antihypertensives, ATC code: C02KX01 Mechanism of action
Farmakoterapeutisk klassifikation: Andre antihypertensiva, ATC-kode: C02KX04.
Pharmacotherapeutic group: other anti-hypertensives, ATC code: C02KX04.
Farmakoterapeutisk klassifikation: Andre antihypertensiver, ATC-kode: C02KX03 Virkningsmekanisme:
Pharmacotherapeutic group: Other antihypertensives, ATC code: C02KX03 Mechanism of action
Farmakoterapeutisk klassifikation: andre antineoplastiske midler, ATC-kode: L01XX46 Virkningsmekanisme og farmakodynamisk virkning
Pharmacotherapeutic group: other antineoplastic agents, ATC code: L01XX46 Mechanism of action and pharmacodynamic effects
Farmakoterapeutisk klassifikation: andre antineoplastiske stoffer ATC-kode: L01XX25 Virkningsmekanisme
Pharmacotherapeutic group: other antineoplastic agents, ATC code: L01XX25 Mechanism of action
Farmakoterapeutisk klassifikation: Andre antineoplastiske stoffer, ATC-kode: L01XX17
Pharmacotherapeutic group: Other antineoplastic agents, ATC code: L01XX17.
Farmakoterapeutisk klassifikation: Andre antineoplastiske stoffer: ATC-kode: L01XX17.
Pharmacotherapeutic group: Other antineoplastic agents : ATC code: L01XX17.
Farmakoterapeutisk klassifikation: Andre antineoplastiske stoffer: ATC-kode: L01XX17.
Pharmacotherapeutic group: Other antineoplastic agents: ATC code: L01XX17.
Farmakoterapeutisk klassifikation: andre antipsykotika, ATC-kode: N05AX12 Virkningsmekanisme
Pharmacotherapeutic group: other antipsychotics, ATC code: N05AX12 Mechanism of action
Farmakoterapeutisk klassifikation: Andre antitrombotika, ATC-kode: B01AF03 Virkningsmekanisme
Pharmacotherapeutic group: Other antithrombotic agents, ATC code: B01AF03 Mechanism of action
Farmakoterapeutisk klassifikation: Andre diagnostiske midler, ATC-kode: V04CX
Pharmacotherapeutic group: Other diagnostic agents, ATC code: V04CX.
Farmakoterapeutisk klassifikation: Andre hæmatologiske midler, lægemidler brugt til behandlingen af heriditært angioødem, ATC-kode: B06AC02.
Pharmacotherapeutic group: Other haematological agents, drugs used to treat hereditary angioedema; ATC code: B06AC02.
Farmakoterapeutisk klassifikation: Andre hæmatologiske midler, midler til arvelig angioødem, ATC- kode: B06AC04.
Pharmacotherapeutic group: Other haematological agents, drugs used in hereditary angioedema, ATC code: B06AC04.
Farmakoterapeutisk klassifikation: Andre immunsuppressiva.
Pharmacotherapeutic group: Other immunosuppressants.
Farmakoterapeutisk klassifikation: Andre lægemidler mod sygdomme i det muskuloskeletale system - enzymer, ATC-kode: M09AB02
Pharmacotherapeutic group: Other Drugs For Disorders of the Musculo-Skeletal System – Enzymes, ATC code: M09AB02
Farmakoterapeutisk klassifikation: Andre lægemidler til sygdomme i bevægeapparatet, ATC-kode: M09AX02
Pharmacotherapeutic group: Other Medicines for Disorders of the Musculo-Skeletal system, ATC code: M09AX02
Farmakoterapeutisk klassifikation: Andre midler med virkning på nervesystemet, ATC-kode: endnu ikke tildelt
Pharmacotherapeutic group: Other nervous system drugs, ATC code: not yet assigned
Farmakoterapeutisk klassifikation: Andre midler mod anæmi, ATC-kode: B03XA03 Virkningsmekanisme
Pharmacotherapeutic group: Other antianemic preparations, ATC code: B03XA03 Mechanism of action
Farmakoterapeutisk klassifikation: Andre midler mod lidelser i nervesystemet: midler mod afhængighedsforstyrrelser: midler mod nicotinafhængighed, ATC-kode: N07BA03
Pharmacotherapeutic group: Other nervous system drugs ; Drugs used in addictive disorders, Drugs used in nicotine, dependence, ATC code: N07BA03
Farmakoterapeutisk klassifikation: Andre midler mod lidelser i nervesystemet: midler mod afhængighedsforstyrrelser: midler mod nicotinafhængighed, ATC-kode: N07BA03
Pharmacotherapeutic group: Other nervous system drugs Drugs used in addictive disorders; Drugs used in nicotine, dependence, ATC code: N07BA03
Farmakoterapeutisk klassifikation: Andre midler mod lidelser i nervesystemet: midler mod afhængighedsforstyrrelser: midler mod nicotinafhængighed, ATC-kode: N07BA03
Pharmacotherapeutic group: Other nervous system drugs; Drugs used in addictive disorders; Drugs used in nicotine, dependence, ATC code: N07BA03
Farmakoterapeutisk klassifikation: Andre midler mod obstipatio, ATC-kode: A06AX04 Virkningsmekanisme
Pharmacotherapeutic group: Other drugs for constipation, ATC Code: A06AX04 Mechanism of action
Farmakoterapeutisk klassifikation: Andre midler til fordøjelsesorganer og stofskifte – enzymer, ATC- kode: A16AB09.
Pharmacotherapeutic group: Other alimentary tract and metabolism products – enzymes, ATC code: A16AB09.
Farmakoterapeutisk klassifikation: Andre midler til fordøjelsesorganer og stofskifte, Enzymer; ATC- kode: endnu ikke tildelt
Pharmacotherapeutic group: Other alimentary tract and metabolism products, Enzymes; ATC code: not yet assigned
Farmakoterapeutisk klassifikation: Andre radiofarmaka til terapeutisk brug, ATC-kode: endnu ikke tildelt.
Pharmacotherapeutic group: Other therapeutic radiopharmaceuticals, ATC code: not yet assigned.
Farmakoterapeutisk klassifikation: Angiotensin II-antagonister og diuretika, ATC-kode: C09DA07
Pharmacotherapeutic group: Angiotensin II antagonists and diuretics, ATC code: C09DA07
Farmakoterapeutisk klassifikation: Angiotensin II-antagonister og diuretika: ATC-kode: C09D A07
Pharmacotherapeutic group: Angiotensin II antagonists and diuretics, ATC code: C09DA07
Farmakoterapeutisk klassifikation: Angiotensin II-antagonister, almindelige, ATC kode: C09CA07.
Pharmacotherapeutic Group: Angiotensin II Antagonists, plain ATC Code: C09CA07.
Farmakoterapeutisk klassifikation: Angiotensin II-antagonister, almindelige, ATC kode: C09CA07.
Pharmacotherapeutic group: Angiotensin II Antagonists, plain, ATC Code: C09CA07.
Farmakoterapeutisk klassifikation: Angiotensin II-receptorantagonister og diuretika, ATC-kode: C09DA07
Pharmacotherapeutic group: Angiotensin II antagonists and diuretics, ATC code:C09DA07.
Farmakoterapeutisk klassifikation: angiotensin-II-antagonister, kombinationer ATC-kode: C09D A04.
Pharmacotherapeutic group: angiotensin-II antagonists, combinations ATC code: C09DA04.
Farmakoterapeutisk klassifikation: Anti-glaukom præparater og miotika, karboanhydrase-hæmmere, ATC kode: S01EC04
Pharmacotherapeutic Group: Antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, ATC code: S01EC04
Farmakoterapeutisk klassifikation: Anti-hæmoragisk blodkoagulationsfaktor XIII, ATC-kode: B02BD11.
Pharmacotherapeutic group: Antihaemorrhagics Blood Coagulation factor XIII, ATC code: B02BD11.
Farmakoterapeutisk klassifikation: anti-Parkinson lægemidler, dopaminergika, ATC-kode: N04BA02 Virkningsmekanisme
Pharmacotherapeutic group: Anti-Parkinson drugs, dopaminergic agents, ATC code: N04BA02 Mechanism of action
Farmakoterapeutisk klassifikation: Anti-Parkinson-lægemiddel, dopaminreceptoragonist, ATC-kode: N04BC05
Pharmacotherapeutic group: anti-Parkinson drugs, dopamine agonists, ATC code: N04BC05.
Farmakoterapeutisk klassifikation: Antibakterielle lægemidler til systemisk brug, carbapenemer, ATC- kode: J01DH03
Pharmacotherapeutic group: Antibacterials for systemic use, carbapenems, ATC code: J01DH03
Farmakoterapeutisk klassifikation: Antibakterielle midler til systemisk brug, aminoglykosider, ATC- kode: J01GB01
Pharmacotherapeutic group: Antibacterials for systemic use, Aminoglycoside antibacterials, ATC Code: J01GB01
Farmakoterapeutisk klassifikation: Antibakterielle midler til systemisk brug, andre antibakterika, ATC-kode: J01XX11
Pharmacotherapeutic group:Antibacterials for systemic use, Other antibacterials, ATC code: J01XX11
Farmakoterapeutisk klassifikation: Antibakterielle midler til systemisk brug, andre cefalosporiner, ATC-kode: J01DI02
Pharmacotherapeutic group: Antibacterials for systemic use, other cephalosporins, ATC code: J01DI02
Farmakoterapeutisk klassifikation: Antibakterielle midler til systemisk brug, glycopeptid antibiotikum, ATC-kode: J01XA03
Pharmacotherapeutic group: Antibacterials for systemic use, glycopeptide antibacterials, ATC code: J01XA03
Farmakoterapeutisk klassifikation: antibakterielle midler til systemisk brug, makrolider, lincosamider og streptogramin, ATC-kode: J01FA15
Pharmacotherapeutic group: antibacterials for systemic use, macrolides, lincosamides and streptogramins, ATC Code: J01FA15.
Farmakoterapeutisk klassifikation: Antibakterielle stoffer til systemisk brug, andre beta­ laktamantibiotika, ATC-kode: J01DF01
Pharmacotherapeutic group: Antibacterials for systemic use, other beta-lactam antibacterials, ATC code: J01DF01
Farmakoterapeutisk klassifikation: Antibiotica og chemotherapeutica til dermatologisk brug, Antibiotica til udvortes brug.
Pharmacotherapeutic group: Antibiotics and chemotherapeutics for dermatological use, Antibiotics for topical use.
Farmakoterapeutisk klassifikation: Antibiotika mod diarré, tarminflammatorika, antibiotika ATC kode: A07AA12.
Pharmacotherapeutic group: Antidiarrheals, intestinal antiinflammatory/antiinfective agents, antibiotics, ATC code: A07AA12
Farmakoterapeutisk klassifikation: Antidiabetica, komb. af orale blod-glucose sænkende midler, ATC- kode: A10BD20
Pharmacotherapeutic group: Drugs used in diabetes, combinations of oral blood glucose lowering drugs, ATC code: A10BD20
Farmakoterapeutisk klassifikation: Antidiabetika, andre blodglucosesænkende midler, ekskl. insuliner, ATC-kode: A10BX09
Pharmacotherapeutic group: Drugs used in diabetes, Other blood glucose lowering drugs, excluding insulins, ATC code: A10BX09
Farmakoterapeutisk klassifikation: Antidiabetika, andre blodglucosesænkende midler, ekskl. insuliner, ATC-kode: A10BX12
Pharmacotherapeutic group: Drugs used in diabetes, Other blood glucose lowering drugs, excl. insulins, ATC code: A10BX12
Farmakoterapeutisk klassifikation: Antidiabetika, blodglucosesænkende midler ekskl. insulin; ATC- kode: A10BG03.
Pharmacotherapeutic group: Drugs used in diabetes, blood glucose lowering drugs; excl. insulins; ATC code: A10BG03.
Farmakoterapeutisk klassifikation: Antidiabetika, blodglucosesænkende midler ekskl. insulin; ATC-kode: A10BG03.
Pharmacotherapeutic group: Drugs used in diabetes, blood glucose lowering drugs, excl. insulins; ATC code: A10BG03.
Farmakoterapeutisk klassifikation: Antidiabetika, blodglucosesænkende midler ekskl. insuliner.
Pharmacotherapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excluding insulins.
Farmakoterapeutisk klassifikation: Antidiabetika, dipeptidylpeptidase-4 (DPP-4)-hæmmere, ATC- kode: A10BH05
Pharmacotherapeutic group: Drugs used in diabetes, dipeptidyl peptidase 4 (DPP-4) inhibitors, ATC code: A10BH05
Farmakoterapeutisk klassifikation: Antidiabetika, dipeptidylpeptidase-4 (DPP-4)-hæmmere.
Pharmacotherapeutic group: Drugs used in diabetes; dipeptidyl peptidase 4 (DPP-4) inhibitors.
Farmakoterapeutisk klassifikation: Antidiabetika, kombinationer af orale blodglucosesænkende idler, ATC-kode: A10BD07
Pharmacotherapeutic group: Drugs used in diabetes, Combinations of oral blood glucose lowering drugs, ATC code: A10BD07
Farmakoterapeutisk klassifikation: Antidiabetika, kombinationer af orale blodsukkersænkende lægemidler; ATC-kode: A10BD06.
Pharmacotherapeutic group: Drugs used in diabetes, combinations of oral blood glucose lowering drugs; ATC code: A10BD06.
Farmakoterapeutisk klassifikation: Antidiabetika, kombinationspræparater, ATC-kode: A10BD03
Pharmacotherapeutic group: Combinations of oral blood glucose lowering medicinal products, ATC code: A10BD03
Farmakoterapeutisk klassifikation: Antidiabetika, kombinationspræparater, ATC-kode: A10BD04
Pharmacotherapeutic group: Combinations of oral blood glucose lowering drugs, ATC code: A10BD04.
Farmakoterapeutisk klassifikation: Antidoter, ATC-kode: V03AB33 Virkningsmekanisme
Pharmacotherapeutic group: Antidotes, ATC code: V03AB33 Mechanism of action
Farmakoterapeutisk klassifikation: Antiemetika og midler mod kvalme, (5HT3)-serotoninantagonister ATC-kode: A04AA02
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5HT3) antagonists ATC code: A04AA02
Farmakoterapeutisk klassifikation: Antiemetika og midler mod kvalme, serotonin (5-HT3)- antagonister, ATC-kode: A04AA55
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5-HT3) antagonists; ATC code: A04AA55
Farmakoterapeutisk klassifikation: Antiemetika og midler mod kvalme, serotonin-(5HT3)-antagonister.
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5HT3) antagonists.
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika ATC-kode: N03A X16 Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics, ATC code: N03AX16.
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika ATC-kode: N03AX16 Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre-analog
Pharmacotherapeutic group: Anti epileptics, other anti-epileptics ATC code: N03AX16 The active substance, pregabalin, is a gamma-aminobutyric acid analogue
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika ATC-kode: N03AX16 Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre-analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics ATC code: N03AX16
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika ATC-kode: N03AX16 Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre-analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics ATC code: N03AX16 The active substance, pregabalin, is a gamma-aminobutyric acid analogue
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika ATC-kode: N03AX16 Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre-analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics ATC code: N03AX16 The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika, ATC-kode: N03A X16 Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics, ATC code: N03AX16.
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika, ATC-kode: N03AX16
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics; ATC code: N03AX16.
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika, ATC-kode: N03AX16 Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre-analog
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics, ATC code: N03AX16.
Farmakoterapeutisk klassifikation: antiepileptika, andre antiepileptika, ATC-kode: N03AX23 Virkningsmekanisme
Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX23 Mechanism of action
Farmakoterapeutisk klassifikation: Antiepileptika, ATC-kode: N03AX16
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics, ATC code: N03AX16.
Farmakoterapeutisk klassifikation: Antihistaminer til systemisk brug, ATC-kode: R06AX27 Virkningsmekanisme
Pharmacotherapeutic group: Other antihistamines for systemic use, ATC code: R06AX27 Mechanism of action
Farmakoterapeutisk klassifikation: Antihistaminer – H1 antagonist, ATC-kode: R06A X27 Virkningsmekanisme
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutisk klassifikation: antihypertensiva til pulmonal arteriel hypertension, ATC-kode: C02KX05
Pharmacotherapeutic group: Antihypertensives for pulmonary arterial hypertension, ATC code: C02KX05
Farmakoterapeutisk klassifikation: Antihypertensiva, antiadrenerge stoffer, centralt virkende ATC- kode: C02AC02.
Pharmacotherapeutic group: Antihypertensives, antiadrenergic agents, centrally acting ATC code: C02AC02.
Farmakoterapeutisk klassifikation: antihæmoragisk koagulationsfaktor IX, ATC kode: B02BD09 Virkningsmekanisme
Pharmacotherapeutic group: Antihaemorrhagic, blood coagulation factor IX; ATC code: B02BD09 Mechanism of action
Farmakoterapeutisk klassifikation: Antikolinergika; ATC-kode: R03BB05.
Pharmacotherapeutic group: Anticholinergics; ATC Code: R03BB05.
Farmakoterapeutisk klassifikation: Antimetaboliter, pyrimidin-analoger, ATC kode L01BC01 Virkningsmekanisme
Pharmacotherapeutic group: Antimetabolites, pyrimidine analogues, ATC code: L01BC01 Mechanism of action
Farmakoterapeutisk klassifikation: Antimykotika til systemisk anvendelse – triazolderivater ATC-kode: J02A C04.
Pharmacotherapeutic group: Antimycotics for systemic use-triazole derivatives, ATC code: J02A C04.
Farmakoterapeutisk klassifikation: Antimykotika til systemisk anvendelse – triazolderivater, ATC-kode: J02A C03
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02A C03
Farmakoterapeutisk klassifikation: Antimykotika til systemisk anvendelse, triazolderivater, ATC- kode: J02AC04.
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02A C04.
Farmakoterapeutisk klassifikation: Antimykotikum til systemisk anvendelse ATC-kode: J02AX04 Virkningsmekanisme
Pharmacotherapeutic group: antimycotics for systemic use, ATC code: J02AX04 Mechanism of action
Farmakoterapeutisk klassifikation: Antineoplastisk middel, andre antineoplastiske midler, monoklonale antistoffer, ATC-kode: L01XC14
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, monoclonal antibodies, ATC code: L01XC14
Farmakoterapeutisk klassifikation: Antineoplastisk middel, sensibiliseringsmidler til fotodynamisk behandling/strålebehandling, ATC-kode: L01XD04
Pharmacotherapeutic group: Antineoplastic agent, Sensitizers used in photodynamic/radiation therapy, ATC code: L01XD04
Farmakoterapeutisk klassifikation: antineoplastisk stof, proteinkinasehæmmer, ATC-kode: L01XE03 Virkningsmekanisme
Pharmacotherapeutic group: antineoplastic agent protein kinase inhibitor, ATC code: L01XE03 Mechanism of action
Farmakoterapeutisk klassifikation: Antineoplastiske midler – andre antineoplastiske midler, ATC-kode: L01XC19
Pharmacotherapeutic group: Antineoplastic agents, other Antineoplastic agents, ATC code: L01XC19.
Farmakoterapeutisk klassifikation: antineoplastiske midler, alkylerende midler , ATC-kode: L01AC01 Virkningsmekanisme
Pharmacotherapeutic group: Antineoplastic agents, Alkylating Agents, ATC code: L01AC01 Mechanism of action
Farmakoterapeutisk klassifikation: Antineoplastiske midler, andre antineoplastiske midler, proteinkinase-hæmmere, ATC-kode: L01XE07
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, protein kinase inhibitor, ATC code: L01XE07
Farmakoterapeutisk klassifikation: Antineoplastiske midler, andre antineoplastiske midler, proteinkinasehæmmere, ATC-kode: L01XE11
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, protein- kinase inhibitors, ATC code: L01XE11
Farmakoterapeutisk klassifikation: Antineoplastiske midler, andre neoplastiske midler, ATC-kode: L01XX32.
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX32.
Farmakoterapeutisk klassifikation: Antineoplastiske midler, antimetabolitter, folsyreanaloger, ATC- kode L01BA04
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, folic acid analogues, ATC code: L01BA04
Farmakoterapeutisk klassifikation: Antineoplastiske midler, antimetabolitter, folsyreanaloger.
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, folic acid analogues.
Farmakoterapeutisk klassifikation: Antineoplastiske midler, antimetabolitter, purinanaloger, ATC- kode: L01B B 07
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, purine analogues, ATC code: L01B B 07
Farmakoterapeutisk klassifikation: antineoplastiske midler, antimetabolitter, purinanaloger; ATC- kode: L01BB02
Pharmacotherapeutic group: antineoplastic agents, antimetabolites, purine analogues, ATC code: L01BB02
Farmakoterapeutisk klassifikation: Antineoplastiske midler, pyrimidin-analoger; ATC-kode: L01BC07 Virkningsmekanisme
Pharmacotherapeutic group: Antineoplastic agents, pyrimidine analogues; ATC code: L01BC07 Mechanism of action
Farmakoterapeutisk klassifikation: Antineoplastiske midler, Taxaner, ATC-kode: L01CD 02 Virkningsmekanisme
Pharmacotherapeutic group: Antineoplastic Agents, Taxanes, ATC Code: L01CD 02 Mechanism of action
Farmakoterapeutisk klassifikation: antineoplastiske stoffer, monoklonale antistoffer, ATC-kode: L01XC16 Virkningsmekanisme
Pharmacotherapeutic group: antineoplastic agents, monoclonal antibodies, ATC code: L01XC16 Mechanism of action
Farmakoterapeutisk klassifikation: Antineoplastiske stoffer, protein-kinasehæmmer, ATC-kode: L01XE01 Virkningsmekanisme
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapeutisk klassifikation: antineoplastiske stoffer, taxaner, ATC-kode: L 01 CD 02 Virkningsmekanisme
Pharmacotherapeutic group: antineoplastic agents, taxanes, ATC Code: L01CD02 Mechanism of action
Farmakoterapeutisk klassifikation: antiparkinson lægemidler, dopa og dopa-derivater, ATC-kode: N04BA03
Pharmacotherapeutic group: anti-parkinson drugs, dopa and dopa derivatives, ATC code: N04BA03
Farmakoterapeutisk klassifikation: antiparkinsonlægemiddel, dopa og dopa-derivater, ATC-kode: N04BA03
Pharmacotherapeutic group: anti-parkinson drugs, dopa and dopa derivatives, ATC code: N04BA03
Farmakoterapeutisk klassifikation: Antiparkinsonmidler, ATC-kode: N04BX01 Virkningsmekanisme:
Pharmaco-therapeutic group: Anti-Parkinson drugs, other dopaminergic agents, ATC code: NO4BX01 Mecahnism of action